Rotational Clinical Pharmacist

Job overview

Our hospitals in Chelsea and Sutton offer both NHS and private patients, inpatient and outpatient care for solid tumours and Haemato-Oncology cancers, including transplants, chemotherapy and clinical trials. We have optimised our Band 6 clinical pharmacist programme to focus on patient facing clinical aspects of pharmacy care. This exciting opportunity is to join a team of specialist pharmacists concentrating on providing the best possible ward based pharmaceutical care. Our department strategy is focussed on providing a pioneering and compassionate service while embedding enhanced roles for pharmacy technicians and a maximised non-medical prescribing workforce.

Main duties of the job

To join our clinical services pharmacy team at the Royal Marsden NHS Foundation Trust liaising closely with other pharmacy team members and Hospital staff.

Detailed job description and main responsibilities

For further information please refer to the job description and personal specification:

a) To provide comprehensive pharmaceutical care, contributing to the multidisciplinary team for clinical units as required, through ward pharmacy services. b) Promote optimal and appropriate drug use and high quality prescribing practice within the Trust. c) To attend all relevant events such as Registrar/Consultant rounds/unit meetings as appropriate. d) To respond appropriately to requests from medical and nursing staff for information and advice about the selection and use of drug therapy. e) Actively participate in audit, drug use reviews and pharmacoeconomic project work. f) Participate in any pharmacy initiatives or working groups as appropriate. g) To support the Pharmacy Clinical Services Manager with the Clinical Governance and Risk Management Strategy within the department and throughout the Trust g) Participate in pharmacy initiatives within the units as appropriate  h) Strive for continuous quality improvement through identifying research questions; developing and contributing to research to further the medicines optimisation agenda in cancer